SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

OBJECTIVE: While COVID-19 vaccination prevents severe infections, poor immunogenicity in immunocompromised people threatens vaccine effectiveness. We analysed the clinical characteristics of patients with rheumatic disease who developed breakthrough COVID-19 after vaccination against SARS-CoV-2. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Jean, Gianfrancesco, Milena, Harrison, Carly, Izadi, Zara, Rush, Stephanie, Lawson-Tovey, Saskia, Jacobsohn, Lindsay, Ja, Clairissa, Hyrich, Kimme L, Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Schäfer, Martin, Frãzao-Mateus, Elsa, Bulina, Inita, Stafford, Frances, Tufan, Abdurrahman, Graver, Christine, Yardımcı, Gözde Kübra, Zepa, Julija, Al Emadi, Samar, Cook, Claire, Abutiban, Fatemah, Dey, Dfiza, Katigbak, Genevieve, Kaufman, Lauren, Kowalski, Emily, Martínez-Martínez, Marco Ulises, Patel, Naomi J, Reyes-Cordero, Greta, Salido, Evelyn, Smith, Ellison, Snow, David, Sparks, Jeffrey, Wise, Leanna, Bhana, Suleman, Gore-Massy, Monique, Grainger, Rebecca, Hausmann, Jonathan, Sirotich, Emily, Sufka, Paul, Wallace, Zachary, Machado, Pedro M, Robinson, Philip C, Yazdany, Jinoos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987210/
https://www.ncbi.nlm.nih.gov/pubmed/35387864
http://dx.doi.org/10.1136/rmdopen-2021-002187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987210/
https://www.ncbi.nlm.nih.gov/pubmed/35387864
http://dx.doi.org/10.1136/rmdopen-2021-002187

Ejemplares similares